Fig 4. Clinical utility of CT-based fibrosis prediction across chemotherapy regimens. (IMAGE)
Caption
Fig 4. Clinical utility of CT-based fibrosis prediction across chemotherapy regimens. (A) Overall survival stratified by CT-predicted fibrosis status (high versus low) in patients receiving AG, FOLFIRINOX, or SOXIRI. (B) Progression-free survival stratified by CT-predicted fibrosis status (high versus low) under the same treatment regimens.
Credit
Copyright © 2025 Qiuxia Yang et al.
Usage Restrictions
Credit must be given to the creator.
License
CC BY